Treatment of neurodegenerative disorders through the blood–brain barrier using nanocarriers-Reference-Cited by-同舟云学术

Treatment of neurodegenerative disorders through the blood–brain barrier using nanocarriers

Published:2018 Issue:36 Volume:10 Page:16962-16983
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Poovaiah N.¹²³⁴,Davoudi Z.¹²³⁴,Peng H.¹²³⁴,Schlichtmann B.¹²³⁴,Mallapragada S.¹²³⁴,Narasimhan B.¹²³⁴,Wang Q.¹²³⁴^ORCID

Affiliation:

1. Department of Chemical and Biological Engineering

2. Iowa State University

3. Ames

4. USA

Abstract

This review highlights the recent advancements in the preparations and applications of nanocarriers in the treatment of neurodegenerative disorders through the blood–brain barrier.

Funder

Crohn's and Colitis Foundation of America

Pharmaceutical Research and Manufacturers of America Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2018/NR/C8NR04073G

Reference217 articles.

1. Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier

2. An update on drug treatment options of Alzheimer's disease

3. Advances in the treatment of Parkinson's disease

4. Present and future drug treatment for Parkinson's disease

5. Huntington's disease

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of chitosan-based nanocarriers as drug delivery systems for brain diseases: Critical challenges, outlooks and promises;International Journal of Biological Macromolecules;2024-10

2. Effect of mesenchymal stem cellsand polyvinyl alcohol-coated selenium nanoparticles on rats with Alzheimer-like phenotypes;IRAN J BASIC MED SCI;2024

3. Nanotechnology-driven Microemulsion Based Intranasal Delivery to Neurotechnology-driven Neuralink: Strategies to Improve Management of Neurodegenerative Disorders;AAPS PharmSciTech;2024-09-12

4. Novel Pyrrole Derivatives as Multi-Target Agents for the Treatment of Alzheimer’s Disease: Microwave-Assisted Synthesis, In Silico Studies and Biological Evaluation;Pharmaceuticals;2024-09-04

5. Brain-specific targeted delivery of therapeutic agents using metal–organic framework-based nanomedicine;Coordination Chemistry Reviews;2024-09